CCM // Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A)
FA <GO> NYSE RQD COCKPIT → CIK 0001472072 ↗ Health Care • Medical/Nursing Services
$3.66 ▼ -0.19
(-4.93%)
MKT CAP: $15.9M • VOL: 9.8K
52W L $3 52W H $7
CCM // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $65.0M | $51.3M | $73.3M |
| YoY Revenue Growth % | +26.6% | -30.0% | — |
| Gross Profit | $3.7M | -$10.8M | — |
| Gross Margin % | 5.7% | -21.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$37.4M | -$72.9M | -$65.2M |
| Operating Margin % | -57.6% | -80.0% | -80.0% |
| Net Income (GAAP) | -$13.3M | -$42.2M | -$41.9M |
| EBITDA (Normalized) | -$30.9M | -$56.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$28.9M | -$54.5M | -$38.9M |
| Capital Expenditures (CapEx) | $8.1M | $20.7M | — |
| Free Cash Flow (FCF) | -$36.9M | -$75.1M | -$38.9M |
| FCF Margin % | -56.8% | -80.0% | -53.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $42.6M | $29.6M | — |
| Total Debt (Short + Long Term) | $352.6M | $369.0M | — |
| Total Stockholders' Equity | -$300.7M | -$312.4M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CCM.